glutathione pathway to triple negative cancer GPX4 in triple-negative breast cancer: A key regulator of ferroptosis and therapeutic target Excessive glutathione intake contributes to
Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Role of Glutathione in Cancer: From Mechanisms to Therapies Apoptosis and glutathione: beyond an antioxidant Cell Death & Differentiation Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Frontiers Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple negative breast cancer
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




